iBio (IBIO) EBT (2010 - 2026)
iBio (IBIO) posted quarterly EBT of -$7.8 million for Q1 2026, down 58.63% year-over-year from -$19.0 million in Q1 2025, and up 13.68% quarter-over-quarter from -$9.1 million in Q4 2025.
iBio (IBIO) EBT (2010 - 2026) Analysis & Trends
iBio (IBIO) has reported EBT for 17 consecutive years, with -$7.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 58.63% year-over-year to -$7.8 million; the TTM figure through Mar 2026 stood at -$27.5 million (down 68.82% YoY), while the FY2025 annual figure was -$81.6 million, down 14.67% from the prior year.
- EBT grew to -$7.8 million in Q1 2026 per IBIO's latest filing, from -$9.1 million in the prior quarter.
- Across five years, EBT topped out at -$2.6 million in Q1 2024 and bottomed at -$10.6 million in Q4 2022.
- Historically, EBT has averaged -$6.0 million across 5 years, with a median of -$5.1 million in 2023.
- Annual changes were most pronounced in 2022 — EBT surged 79.75% — and 2025, when it sank 104.43%.
- iBio's EBT stood at -$10.6 million in 2022, then surged by 57.51% to -$4.5 million in 2023, then advanced by 0.89% to -$4.4 million in 2024, then tumbled by 104.43% to -$9.1 million in 2025, then gained by 13.68% to -$7.8 million in 2026.
- Business Quant data shows IBIO's EBT at -$7.8 million in Q1 2026, -$9.1 million in Q4 2025, and -$5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | iBio | 175.21 Mn | 175.21 Mn | - | -7.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.85 Mn |
| Dec 31, 2025 | -9.09 Mn |
| Sep 30, 2025 | -5.72 Mn |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | -4.95 Mn |
| Dec 31, 2024 | -4.45 Mn |
| Sep 30, 2024 | -3.99 Mn |
| Jun 30, 2024 | -2.91 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Dec 31, 2023 | -4.49 Mn |
| Sep 30, 2023 | -5.07 Mn |
| Jun 30, 2023 | -4.93 Mn |
| Mar 31, 2023 | -6.28 Mn |
| Dec 31, 2022 | -10.56 Mn |
| Sep 30, 2022 | -7.54 Mn |
| Jun 30, 2022 | -10.39 Mn |
| Mar 31, 2022 | -6.75 Mn |
| Dec 31, 2021 | -7.21 Mn |
| Sep 30, 2021 | -37.22 Mn |
| Jun 30, 2021 | -10.09 Mn |